Financial statements Labfarm
Balance sheet data of LABFARM
|
Year
|
2021
|
2023
|
|---|---|---|
| Total assets | 278 755,34 | 3 286 059,29 |
| A. Fixed assets | 17 170,00 | 3 153 486,30 |
| B. Current assets | 261 585,34 | 132 572,99 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 278 755,34 | 3 286 059,29 |
| A. Equity | -56 763,91 | 20 002,83 |
| B. Liabilities and provisions for liabilities | 335 519,25 | 3 266 056,46 |
| I. Long-term liabilities | 258 658,16 | 1 351 264,22 |
| II. Short-term liabilities | 76 861,09 | 1 914 792,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.